Related references
Note: Only part of the references are listed.The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
Kathryn M. Lemberg et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
Steven D. Rhodes et al.
HUMAN MOLECULAR GENETICS (2019)
Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients
Guanghui Zhu et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1
Elliott Robinson et al.
ELIFE (2019)
The Diagnosis and Management of Neurofibromatosis Type 1
K. Ina Ly et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Optic Pathway Gliomas in Neurofibromatosis Type 1
Cynthia J. Campen et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1
Giovanni Corsello et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia
Santasree Banerjee et al.
ONCOTARGET (2017)
Cancer of the Peripheral Nerve in Neurofibromatosis Type 1
Verena Staedtke et al.
NEUROTHERAPEUTICS (2017)
Neurofibromatosis Type 1 Accompanied by Craniofacial Pain: Literature Review and Descriptive Case
Chunghwan Son et al.
JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE (2017)
Annual review of children with neurofibromatosis type 1
B. M. Dunning-Davies et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2016)
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies
Rami N. Al-Rohil et al.
CANCER (2016)
Congenital Retroperitoneal Teratoma in Neurofibromatosis Type 1
Patrick Yap et al.
PEDIATRIC BLOOD & CANCER (2016)
Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia
Van Royen Kjell et al.
EUROPEAN JOURNAL OF PEDIATRICS (2016)
Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only
D. G. Evans et al.
EBIOMEDICINE (2016)
Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma
Patrizia Bruzzi et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning
Corina Anastasaki et al.
HUMAN MOLECULAR GENETICS (2015)
Strabismus in patients with neurofibromatosis type 1-associated optic pathway glioma
Reut Parness-Yossifon et al.
JOURNAL OF AAPOS (2015)
A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1
Teresa Esposito et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms
Stephan C. J. Huijbregts et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2015)
Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1
Salmafatima S. Abadin et al.
JOURNAL OF PEDIATRICS (2015)
Unraveling Gene Interactions in Patients with Neurofibromatosis Type 1
Beth A. Pletcher et al.
JOURNAL OF PEDIATRICS (2015)
Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1
Nilay Duman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Nevus Anemicus: A Distinctive Cutaneous Finding in Neurofibromatosis Type 1
Angela Hernandez-Martin et al.
PEDIATRIC DERMATOLOGY (2015)
In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells
Jennifer Allouche et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
Brian Weiss et al.
NEURO-ONCOLOGY (2015)
Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing
Elisabete Hernandez-Imaz et al.
PLOS ONE (2015)
Massive Plexiform Neurofibroma of the Neck and Larynx
Mohammad Kamal Mobashir et al.
INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY (2015)
In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients
Raffaele Parrozzani et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands
R. van Minkelen et al.
CLINICAL GENETICS (2014)
Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1
Jean de la Croix Ndong et al.
NATURE MEDICINE (2014)
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C. Widemann et al.
NEURO-ONCOLOGY (2014)
Sirolimus Improves Pain in NF1 Patients With Severe Plexiform Neurofibromas
Camille Hua et al.
PEDIATRICS (2014)
Nilotinib Is More Potent than Imatinib for Treating Plexiform Neurofibroma In Vitro and In Vivo
Jiang Wei et al.
PLOS ONE (2014)
The NF1 gene revisited - from bench to bedside
Yoon-Sim Yap et al.
ONCOTARGET (2014)
Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice
Kelly A. Diggs-Andrews et al.
ANNALS OF NEUROLOGY (2013)
NF1 Molecular Characterization and Neurofibromatosis Type I Genotype-Phenotype Correlation: The French Experience
Audrey Sabbagh et al.
HUMAN MUTATION (2013)
Narrowband ultraviolet B irradiation increases the serum level of vitamin D3 in patients with neurofibromatosis 1
Juichiro Nakayama et al.
JOURNAL OF DERMATOLOGY (2013)
Radiofrequency Ablation and Excision of Multiple Cutaneous Lesions in Neurofibromatosis Type 1
Seong-Hun Kim et al.
ARCHIVES OF PLASTIC SURGERY-APS (2013)
A novel NF1 mutation in a Chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality
H. -X. Tong et al.
GENETICS AND MOLECULAR RESEARCH (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
Kent A. Robertson et al.
LANCET ONCOLOGY (2012)
Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Adila Alkindy et al.
HUMAN GENOMICS (2012)
Carbon Dioxide Laser Treatment of Cutaneous Neurofibromas
Yi Zhen Chiang et al.
DERMATOLOGY AND THERAPY (2012)
The Pathoetiology of Neurofibromatosis 1
Eeva-Mari Jouhilahti et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Evolving Pattern with Age of Cutaneous Signs in Neurofibromatosis Type 1: A Cross-Sectional Study of 728 Patients
T. A. Duong et al.
DERMATOLOGY (2011)
A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations
Saba Sharif et al.
JOURNAL OF MEDICAL GENETICS (2011)
A Highly Sensitive Genetic Protocol to Detect NF1 Mutations
Maria Carmen Valero et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
A Rare Vulvar Manifestation of Neurofibromatosis 1 in a Teen
Josh C. Skorupski et al.
Journal of Pediatric and Adolescent Gynecology (2011)
Phase I trial of pegylated interferon-α-2b in young patients with plexiform neurofibromas
R. I. Jakacki et al.
NEUROLOGY (2011)
Neurobiology of Attention Deficit/Hyperactivity Disorder
Diane Purper-Ouakil et al.
PEDIATRIC RESEARCH (2011)
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice
Jacquelyn A. Brown et al.
HUMAN MOLECULAR GENETICS (2010)
NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype
Eric Pasmant et al.
HUMAN MUTATION (2010)
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions
V-F Mautner et al.
JOURNAL OF MEDICAL GENETICS (2010)
Brain structure and function in neurofibromatosis type 1: current concepts and future directions
Jonathan M. Payne et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Adult hippocampal neurogenesis and related neurotrophic factors
Eugene Lee et al.
BMB REPORTS (2009)
Congenital pseudarthrosis of neurofibromatosis type 1: Impaired osteoblast differentiation and function and altered NF1 gene expression
Hannu-Ville Leskela et al.
BONE (2009)
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype
E. Pasmant et al.
JOURNAL OF MEDICAL GENETICS (2009)
SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype
G. Spurlock et al.
JOURNAL OF MEDICAL GENETICS (2009)
Neurofibromatosis type 1
Kevin P. Boyd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/- and c-kit-Dependent Bone Marrow
Feng-Chun Yang et al.
CELL (2008)
Neurofibromin as a regulator of melanocyte development and differentiation
Ganesh Diwakar et al.
JOURNAL OF CELL SCIENCE (2008)
Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes
Sofie De Schepper et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Congenital pseudarthrosis of the tibia
Kelly L. Vander Have et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2008)
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
Hilde Brems et al.
NATURE GENETICS (2007)
Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1
Ophelia Maertens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic et al.
PEDIATRIC NEUROLOGY (2007)
Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed-radio frequency in combination with topical application of vitamin D3 ointment
Yuichi Yoshida et al.
JOURNAL OF DERMATOLOGY (2007)
Molecular diagnosis of neurofibromatosis type 1: 2 years experience
Sian Griffiths et al.
FAMILIAL CANCER (2007)
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Rosalie E. Ferner et al.
JOURNAL OF MEDICAL GENETICS (2007)
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in Exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation
M. Upadhyaya et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae
Florent Elefteriou et al.
CELL METABOLISM (2006)
Comprehensive NF1 screening on cultured Schwann cells from neurofibromas
Ophelia Maertens et al.
HUMAN MUTATION (2006)
Radiofrequency in the treatment of craniofacial plexiform neurofibromatosis: A pilot study
B Baujat et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Gastrointestinal stromal tumors in patients with neurofibromatosis 1 - A clinicopothologic and molecular genetic study of 45 cases
M Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Forebrain substrates of reward and motivation
RA Wise
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome
A De Luca et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
SL Hyman et al.
NEUROLOGY (2005)
Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome
Katharina Wimmer
WIENER MEDIZINISCHE WOCHENSCHRIFT (2005)
Cutaneous malignant melanoma and neurofibromatosis type 1
B Guillot et al.
MELANOMA RESEARCH (2004)
Peripheral nerve tumors: management strategies and molecular insights
AK Bhattacharyya et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Intelligence in individuals with a neurofibromatosis type 1 microdeletion
MJ Descheemaeker et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2
M Venturin et al.
JOURNAL OF MEDICAL GENETICS (2004)
Neurofibromatosis in children with rhabdomyosarcoma: A report from the intergroup Rhabdomyosarcoma Study IV
L Sung et al.
JOURNAL OF PEDIATRICS (2004)
Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome
A King et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Optic pathway gliomas in children with and without neurofibromatosis 1
E Czyzyk et al.
JOURNAL OF CHILD NEUROLOGY (2003)
Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients -: art. no. e82
E Ars et al.
JOURNAL OF MEDICAL GENETICS (2003)
Genetics of neurofibromatosis 1 and the NF1 gene
D Viskochil
JOURNAL OF CHILD NEUROLOGY (2002)
Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1
L. De Smet et al.
JOURNAL OF MEDICAL GENETICS (2002)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Neurofibromin regulates G protein-stimulated adenylyl cyclase activity
JY Tong et al.
NATURE NEUROSCIENCE (2002)
Postoperative nomogram for 12-year sarcoma-specific death
MW Kattan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of ADHD in neurofibromatosis type 1
VF Mautner et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2002)
The clinical and diagnostic implications of mosaicism in the neurofibromatoses
M Ruggieri et al.
NEUROLOGY (2001)
Carbon dioxide laser for removal of multiple cutaneous neurofibromas
JC Moreno et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Share Paper
